Compound information
- Natural Products
- ZC1776997
- Molecular Formula
- C17H19ClN4O
- Molecular Weight
- 330.124738908 g/mol
- Structure
-
- IUPAC Name
- N-(4-chlorophenyl)-4-(3-pyridylmethyl)piperazine-1-carboxamide
- InChI
- InChI=1S/C17H19ClN4O/c18-15-3-5-16(6-4-15)20-17(23)22-10-8-21(9-11-22)13-14-2-1-7-19-12-14/h1-7,12H,8-11,13H2,(H,20,23)
- InChI Key
- YFRQAFVUPMAMIP-UHFFFAOYSA-N
- SMILES
- O=C(Nc1ccc(Cl)cc1)N1CCN(Cc2cccnc2)CC1
- Source
- ZINC000020467106
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 3 |
Heteroatom Count | 6 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 48.47 Å2 | LogP | 2.246 |
LogS | -2.942 | LogD | 2.718 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.75 | Pgp substrate | 0.874 |
HIA | 0.953 | F20 % | 0.985 |
F30 % | 0.945 | Caco-2 | -4.794 |
MDCK | -5.02 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.387 | PPB | 78.066 |
VD | 1.097 | Fu | 0.665 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.262 | CYP1A2 substrate | 0.778 |
CYP2A6 substrate | 0.833 | CYP2B6 substrate | 0.724 |
CYP2C19 inhibitor | 0.807 | CYP2C19 substrate | 0.845 |
CYP2C8 substrate | 0.894 | CYP2C9 inhibitor | 0.815 |
CYP2C9 substrate | 0.963 | CYP2D6 inhibitor | 0.985 |
CYP2D6 substrate | 0.998 | CYP2E1 substrate | 0.882 |
CYP3A4 inhibitor | 0.148 | CYP3A4 substrate | 0.988 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.533 | CL | 12.261 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.724 | Hepatotoxicity | 0.824 |
Mutagenicity | 0.001 | Rat Oral Acute Toxicity | 0.858 |
FDAMDD | 0.535 | Skin Sensitization | 0.92 |
Carcinogenicity | 0.075 | Eye Corrosion | 0.002 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.879 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.613 | IGC50 | 2.845 |
LC50FM | 0.883 | LC50DM | -3.076 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.319 | NR-AR-LBD | 0.205 |
NR-AhR | 0.796 | NR-Aromatase | 0.035 |
NR-ER | 0.346 | NR-ER-LBD | 0.313 |
NR-PPAR-gamma | 0.149 | SR-ARE | 0.87 |
SR-ATAD5 | 0.364 | SR-HSE | 0.198 |
SR-MMP | 0.025 | SR-p53 | 0.095 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.